4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001193125-26-429075
Director bought 3,680 shares at $27.08 ($99,636)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Silva Paul M Director | 2026-10-22 | Purchase | +3,680 | $27.08 | $99,636 | 3,680 | I |
| Open-market purchases · 3,680 sh · avg $27.08 · $99,636 | |||||||
Loading xslF345X06/ownership.xml…